CDK12: A Potent Target and Biomarker for Human Cancer Therapy
Shujing Liang1,2,3, Lifang Hu1,2,3, Zixiang Wu1,2,3
1Laboratory for Bone Metabolism, Xi'an Key Laboratory of Special Medicine and Health Engineering, Northwestern Polytechnical University, Xi'an 710072, China.
Abstract:
Cyclin-dependent kinases (CDKs) are a group of serine/threonine protein kinases and play crucial roles in various cellular processes by regulating cell cycle and gene transcription. Cyclin-dependent kinase 12 (CDK12) is an important transcription-associated CDK. It shows versatile roles in regulating gene transcription, RNA splicing, translation, DNA damage response (DDR), cell cycle progression and cell proliferation. Recently, increasing evidence demonstrates the important role of CDK12 in various human cancers, illustrating it as both a biomarker of cancer and a potential target for cancer therapy. Here, we summarize the current knowledge of CDK12, and review the research advances of CDK12's biological functions, especially its role in human cancers and as a potential target and biomarker for cancer therapy.
Insights
Cyclin-dependent kinase 12 (CDK12) regulates crucial cellular functions including transcription and DNA repair. Emerging research highlights CDK12
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Cyclin-dependent kinases (CDKs) are essential serine/threonine protein kinases regulating fundamental cellular processes.
- Cyclin-dependent kinase 12 (CDK12) is a key transcription-associated CDK involved in diverse cellular functions.
Purpose of the Study:
- To summarize current knowledge on CDK12's biological functions.
- To review research advances concerning CDK12's role in human cancers.
- To highlight CDK12 as a potential cancer biomarker and therapeutic target.
Main Methods:
- Literature review of existing research on CDK12.
- Analysis of CDK12's involvement in gene transcription, RNA splicing, and DNA damage response (DDR).
- Examination of CDK12's implications in cell cycle progression and proliferation.
Main Results:
- CDK12 plays versatile roles in regulating transcription, RNA processing, and DNA repair.
- Evidence increasingly implicates CDK12 in the development and progression of various human cancers.
- CDK12 demonstrates potential as both a diagnostic biomarker and a therapeutic target in oncology.
Conclusions:
- CDK12 is a critical regulator of essential cellular processes.
- CDK12's significant role in human cancers positions it as a promising target for novel cancer therapies.
- Further research into CDK12 functions may unlock new strategies for cancer treatment and diagnosis.
More Related Videos
Related Concept Videos
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of Cdk Activity
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mitogens and the Cell Cycle
Positive Regulator Molecules
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...


